FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2921107593> ?p ?o ?g. }

• W2921107593 endingPage "2036" @default.
• W2921107593 startingPage "2023" @default.
• W2921107593 abstract "Abstract Parkinson’s disease is characterized by the progressive loss of pigmented dopaminergic neurons in the substantia nigra and associated striatal deafferentation. Neuromelanin content is thought to reflect the loss of pigmented neurons, but available data characterizing its relationship with striatal dopaminergic integrity are not comprehensive or consistent, and predominantly involve heterogeneous samples. In this cross-sectional study, we used neuromelanin-sensitive MRI and the highly specific dopamine transporter PET radioligand, 11C-PE2I, to assess the association between neuromelanin-containing cell levels in the substantia nigra pars compacta and nigrostriatal terminal density in vivo, in 30 patients with bilateral Parkinson’s disease. Fifteen healthy control subjects also underwent neuromelanin-sensitive imaging. We used a novel approach taking into account the anatomical and functional subdivision of substantia nigra into dorsal and ventral tiers and striatal nuclei into pre- and post-commissural subregions, in accordance with previous animal and post-mortem studies, and consider the clinically asymmetric disease presentation. In vivo, Parkinson’s disease subjects displayed reduced neuromelanin levels in the ventral (−30 ± 28%) and dorsal tiers (−21 ± 24%) as compared to the control group [F(1,43) = 11.95, P = 0.001]. Within the Parkinson’s disease group, nigral pigmentation was lower in the ventral tier as compared to the dorsal tier [F(1,29) = 36.19, P < 0.001] and lower in the clinically-defined most affected side [F(1,29) = 4.85, P = 0.036]. Similarly, lower dopamine transporter density was observed in the ventral tier [F(1,29) = 76.39, P < 0.001] and clinically-defined most affected side [F(1,29) = 4.21, P = 0.049]. Despite similar patterns, regression analysis showed no significant association between nigral pigmentation and nigral dopamine transporter density. However, for the clinically-defined most affected side, significant relationships were observed between pigmentation of the ventral nigral tier with striatal dopamine transporter binding in pre-commissural and post-commissural striatal subregions known to receive nigrostriatal projections from this tier, while the dorsal tier correlated with striatal projection sites in the pre-commissural striatum (P < 0.05, Benjamini-Hochberg corrected). In contrast, there were no statistically significant relationships between these two measures in the clinically-defined least affected side. These findings provide important insights into the topography of nigrostriatal neurodegeneration in Parkinson’s disease, indicating that the characteristics of disease progression may fundamentally differ across hemispheres and support post-mortem data showing asynchrony in the loss of neuromelanin-containing versus tyrosine hydroxylase positive nigral cells." @default.
• W2921107593 created "2019-03-22" @default.
• W2921107593 creator A5009870662 @default.
• W2921107593 creator A5028805520 @default.
• W2921107593 creator A5031881924 @default.
• W2921107593 creator A5062496257 @default.
• W2921107593 creator A5065874626 @default.
• W2921107593 creator A5068228767 @default.
• W2921107593 creator A5072684321 @default.
• W2921107593 creator A5074639990 @default.
• W2921107593 creator A5078023911 @default.
• W2921107593 creator A5079875253 @default.
• W2921107593 date "2019-05-05" @default.
• W2921107593 modified "2023-10-17" @default.
• W2921107593 title "Relationship between neuromelanin and dopamine terminals within the Parkinson’s nigrostriatal system" @default.
• W2921107593 cites W1533056363 @default.
• W2921107593 cites W1829251706 @default.
• W2921107593 cites W1913653254 @default.
• W2921107593 cites W1967659552 @default.
• W2921107593 cites W1971287979 @default.
• W2921107593 cites W1976749972 @default.
• W2921107593 cites W1978793506 @default.
• W2921107593 cites W1984954124 @default.
• W2921107593 cites W1993253047 @default.
• W2921107593 cites W1994248961 @default.
• W2921107593 cites W2004240610 @default.
• W2921107593 cites W2005582119 @default.
• W2921107593 cites W2008560062 @default.
• W2921107593 cites W2014969622 @default.
• W2921107593 cites W2017923539 @default.
• W2921107593 cites W2018944162 @default.
• W2921107593 cites W2029942338 @default.
• W2921107593 cites W2030109016 @default.
• W2921107593 cites W2032587951 @default.
• W2921107593 cites W2035229535 @default.
• W2921107593 cites W2037045108 @default.
• W2921107593 cites W2049233581 @default.
• W2921107593 cites W2054121399 @default.
• W2921107593 cites W2055192338 @default.
• W2921107593 cites W2058668664 @default.
• W2921107593 cites W2066870719 @default.
• W2921107593 cites W2071189762 @default.
• W2921107593 cites W2079142438 @default.
• W2921107593 cites W2081749744 @default.
• W2921107593 cites W2086361121 @default.
• W2921107593 cites W2089085990 @default.
• W2921107593 cites W2090592015 @default.
• W2921107593 cites W2092462980 @default.
• W2921107593 cites W2115862120 @default.
• W2921107593 cites W2117671988 @default.
• W2921107593 cites W2123983635 @default.
• W2921107593 cites W2129167248 @default.
• W2921107593 cites W2133149158 @default.
• W2921107593 cites W2140978740 @default.
• W2921107593 cites W2142525406 @default.
• W2921107593 cites W2149885167 @default.
• W2921107593 cites W2155175950 @default.
• W2921107593 cites W2169587139 @default.
• W2921107593 cites W2169670248 @default.
• W2921107593 cites W2250240315 @default.
• W2921107593 cites W2261476050 @default.
• W2921107593 cites W2311228285 @default.
• W2921107593 cites W2321599916 @default.
• W2921107593 cites W2336893408 @default.
• W2921107593 cites W2481634574 @default.
• W2921107593 cites W2516289434 @default.
• W2921107593 cites W2531636604 @default.
• W2921107593 cites W2594776413 @default.
• W2921107593 cites W2601685512 @default.
• W2921107593 cites W2689471436 @default.
• W2921107593 cites W2761589214 @default.
• W2921107593 cites W2792171782 @default.
• W2921107593 cites W2797850641 @default.
• W2921107593 cites W2900464582 @default.
• W2921107593 cites W2952462837 @default.
• W2921107593 cites W2977883299 @default.
• W2921107593 cites W4256196726 @default.
• W2921107593 doi "https://doi.org/10.1093/brain/awz120" @default.
• W2921107593 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6664390" @default.
• W2921107593 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31056699" @default.
• W2921107593 hasPublicationYear "2019" @default.
• W2921107593 type Work @default.
• W2921107593 sameAs 2921107593 @default.
• W2921107593 citedByCount "44" @default.
• W2921107593 countsByYear W29211075932019 @default.
• W2921107593 countsByYear W29211075932020 @default.
• W2921107593 countsByYear W29211075932021 @default.
• W2921107593 countsByYear W29211075932022 @default.
• W2921107593 countsByYear W29211075932023 @default.
• W2921107593 crossrefType "journal-article" @default.
• W2921107593 hasAuthorship W2921107593A5009870662 @default.
• W2921107593 hasAuthorship W2921107593A5028805520 @default.
• W2921107593 hasAuthorship W2921107593A5031881924 @default.
• W2921107593 hasAuthorship W2921107593A5062496257 @default.
• W2921107593 hasAuthorship W2921107593A5065874626 @default.
• W2921107593 hasAuthorship W2921107593A5068228767 @default.
• W2921107593 hasAuthorship W2921107593A5072684321 @default.
• W2921107593 hasAuthorship W2921107593A5074639990 @default.

• next